Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IPSEF
Recent news which mentions IPSEF
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
June 11, 2024
Tickers
GNFT
IPSEF
IPSEY
NEWS
Tags
Health Care
AI Generated
News
From
Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
Tickers
EXEL
IPSEF
IPSEY
RHHBF
Tags
Benzinga
Biotech
Expert Ideas
From
Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
May 22, 2023
Tickers
CBAY
DRRX
GNFT
ICPT
Tags
Market News
IPSEY
Analyst Ratings
From
Benzinga
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
January 09, 2023
Tickers
ALBO
IPSEF
IPSEY
Tags
IPSEY
why it's moving
M&A
From
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
November 09, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
News
Penny Stocks
Trading Ideas
From
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
August 03, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Why Is Epizyme (EPZM) Stock Up 75% Today?
June 27, 2022
Tickers
EPZM
IPSEF
Tags
NASDAQ:EPZM,OTCMKTS:IPSEF
Market News
IPSEF
From
InvestorPlace
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
June 27, 2022
Tickers
EPZM
IPSEF
IPSEY
Tags
M&A
Market News
why it's moving
From
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
IPSEY
General
IPSEF
From
Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
News
Briefs
EXEL
From
Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
January 24, 2022
Tickers
IPSEF
IPSEY
Tags
Briefs
News
Health Care
From
Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
December 17, 2021
Tickers
GNFT
IPSEF
IPSEY
Tags
Benzinga
Phase 3 Trial
Biotech
From
Benzinga
Ipsen Stock Declines After Pulling Rare Disease Application
August 13, 2021
Tickers
IPSEF
IPSEY
Tags
Trading Ideas
Health Care
New Drug Application
From
Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
August 02, 2021
Tickers
IPSEF
IPSEY
XCUR
Tags
IPSEF
General
Neurodegenerative Disorder
From
Benzinga
Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
July 27, 2021
Tickers
IPSEF
IPSEY
Tags
Health Care
Benzinga
Biotech
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.